English
Trade
Wockhardt share price
High risk
You have to be logged in to add this to Watchlist.- ₹1,368.70(1.66%)November 17, 2025 15:52:00 PM IST
- NSE
- BSE
- Vol : 407.67K (NSE + BSE)Last 20 day avg : 669.30 K
Wockhardt is trading 1.66% upper at Rs 1,368.70 as compared to its last closing price. Wockhardt has been trading in the price range of 1,399.00 & 1,346.55. Wockhardt has given -5.04% in this year & 0.58% in the last 5 days. The company posted a net profit of 78.00 Crores in its last quarter.Listed peers of Wockhardt include Ajanta Pharma (-0.65%), Gland Pharma (-0.87%), Wockhardt (1.66%).The Mutual Fund holding in Wockhardt was at 7.89% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Wockhardt was at 7.09% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Nov 17, 2025, 01:50 PM UTC
- BetaHigh volatility1.45Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.46The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values5.03The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Wockhardt News
Wockhardt Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable
The company's revenue fell during September quarter by 3.34% from Rs 809.00 crore to Rs 782.00 crore, year-on-year- Company has registered a profit of 78.00 cr vs a loss of 22.00 cr in the same quarter last year.
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
Wockhardt Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 1,471.17
- R2
- 1,527.38
- R3
- 1,620.97
Pivot1,377.58
- S1
- 1,321.37
- S2
- 1,227.78
- S3
- 1,171.57
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Wockhardt Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma | Bearish | 2,506.50 | -0.65 | 31,290.31 | 35.77 | 8.67 | 2.05 | 0.92 |
| Gland Pharma | Moderately Bearish | 1,815.00 | -0.87 | 29,920.45 | 44.21 | 3.37 | 0.96 | 1.17 |
| Wockhardt | Neutral | 1,368.70 | 1.66 | 22,239.40 | - | 6.51 | - | 30.00 |
| Piramal Pharma | Bearish | 195.75 | 1.01 | 25,979.82 | 177.36 | 3.3 | 0.07 | 40.78 |
| Syngene International | Moderately Bullish | 652.35 | -0.28 | 26,346.16 | 54.31 | 5.44 | 0.20 | 8.65 |
Wockhardt Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Wockhardt is currently unavailable
Please check back later.
Shareholding Insights
- Pledged found - Promoter(s) have pledged 21.30% of shares.
- Promoter(s) have increased pledged shares to 15.64% from 21.30% earlier.
- Promoter(s) holding is moderate at 49.08%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.19 percentage points from previous quarter
- Mutual Funds holding has decreased by 0.13 percentage points from previous quarter
Mutual Fund Ownership
View allWockhardt Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-03 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Fund Raising |
| 2025-02-07 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
About the company Wockhardt
- IndustryBiotechnology & Drugs
- ISININE049B01025
- BSE Code532300
- NSE CodeWOCKPHARMA
Wockhardt Limited is a research-based global pharmaceutical and biotech company. Its segments include Ratings & ancillary services and Research & Analytics. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL TABLET, METHYCOBAL INJ, METHYCOBAL D, HAPID, PROXYFEN NANO GEL, LIVATIRA TABLET, LIVATIRA INJ, GABAWOK NT 100, GABAWOK NT 400, ETOBRIX 90, ETOBRIX TH4, ETOBRIX P, GLARZEN CARTRIDGE, GLARZEN DISPOPEN 2, ESOWOK D, TERITIDE, GLIMADAY, SITAWOK, GLARITUS, TRIMETADAY, MOPADAY, INOGLA, and ZINODAP. The Company has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.
Wockhardt Share Price FAQs
Wockhardt is trading at 1368.70 as on Mon Nov 17 2025 10:22:00. This is 1.66% upper as compared to its previous closing price of 1346.30.
The market capitalization of Wockhardt is 22239.40 Cr as on Mon Nov 17 2025 10:22:00.
The 52 wk high for Wockhardt is 1870.00 whereas the 52 wk low is 1109.60
Wockhardt can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 28.85
- Dividend Yield: 0.00%
- D/E ratio: 0.54
Wockhardt reported a net profit of -47.00 Cr in 2025.
The Mutual Fund Shareholding was 7.89% at the end of 30 Sep 2025.
Quick Links